Advertisement

Picture EBD Group BIO-Europe 2021 Digital BEU2021 650x80
Organisation › Details

Wilson Therapeutics AB

Wilson Therapeutics is a privately-held biopharmaceutical company focused on improving the lives of patients with Wilson's disease through development of new treatment options and support for increased awareness and education about Wilson's disease. The Company's lead product candidate, WTX101, is currently in clinical development as a treatment for Wilson's disease, a rare genetic disease that affects approximately 1 in 15,000 people worldwide. Wilson Therapeutics was founded by HealthCap, one of the largest venture capital firms in Europe specialized in life sciences. *

 

Period Start 2012-01-01 established
  Group Alexion (Group)
Products Industry drug development
  Industry 2 WTX101 (bis-choline tetrahiomolybdate)
Person Person Hansson, Jonas (Wilson Therapeutics 201404 CEO)
     
Region Region Stockholm
  Country Sweden
  Street 15 Västra Trädgardsgatan
  City 11153 Stockholm
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for �About Section�: 
     
   
Record changed: 2019-01-18

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for Alexion (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80




» top